Sinovac Biotech Stock Operating Margin
Sinovac Biotech fundamentals help investors to digest information that contributes to Sinovac Biotech's financial success or failures. It also enables traders to predict the movement of Sinovac Stock. The fundamental analysis module provides a way to measure Sinovac Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sinovac Biotech stock.
Sinovac |
Sinovac Operating Margin Analysis
Sinovac Biotech's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Sinovac Biotech Operating Margin | 15.86 % |
Most of Sinovac Biotech's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sinovac Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Sinovac Biotech has an Operating Margin of 15.86%. This is 145.21% lower than that of the Healthcare sector and 114.15% lower than that of the Biotechnology industry. The operating margin for all United States stocks is notably lower than that of the firm.
Sinovac Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sinovac Biotech's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sinovac Biotech could also be used in its relative valuation, which is a method of valuing Sinovac Biotech by comparing valuation metrics of similar companies.Sinovac Biotech is currently under evaluation in operating margin category among related companies.
Sinovac Fundamentals
Return On Equity | 11.03 | ||||
Return On Asset | 4.53 | ||||
Profit Margin | 10.02 % | ||||
Operating Margin | 15.86 % | ||||
Current Valuation | 614.58 M | ||||
Shares Outstanding | 98.9 M | ||||
Shares Owned By Insiders | 15.89 % | ||||
Shares Owned By Institutions | 23.11 % | ||||
Number Of Shares Shorted | 199.77 K | ||||
Price To Earning | 48.65 X | ||||
Price To Book | 2.29 X | ||||
Price To Sales | 2.16 X | ||||
Revenue | 213.17 M | ||||
Gross Profit | 213.58 M | ||||
EBITDA | 38.49 M | ||||
Net Income | 15.35 M | ||||
Cash And Equivalents | 176.72 M | ||||
Cash Per Share | 1.79 X | ||||
Total Debt | 93.13 M | ||||
Debt To Equity | 0.28 % | ||||
Current Ratio | 2.98 X | ||||
Book Value Per Share | 2.83 X | ||||
Cash Flow From Operations | 22.17 M | ||||
Short Ratio | 47.51 X | ||||
Earnings Per Share | 0.13 X | ||||
Number Of Employees | 910 | ||||
Beta | 0.08 | ||||
Market Capitalization | 460.25 M | ||||
Total Asset | 202.98 M | ||||
Retained Earnings | (8.28 M) | ||||
Working Capital | 70.52 M | ||||
Current Asset | 128.52 M | ||||
Current Liabilities | 58 M | ||||
Z Score | 3.4 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sinovac Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sinovac Biotech's short interest history, or implied volatility extrapolated from Sinovac Biotech options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Sinovac Stock
If you are still planning to invest in Sinovac Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sinovac Biotech's history and understand the potential risks before investing.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |